Results 81 to 90 of about 57,669 (284)

Policy gaps in type 1 diabetes: A UK audit of National Governing Bodies

Diabetic Medicine, EarlyView.
Abstract Aims National Governing Bodies (NGBs) for sport in the United Kingdom (UK) are responsible for setting standards and ensuring safe, inclusive participation for all, including people with type 1 diabetes (T1D). This audit systematically assessed the extent and quality of policy provision among UK‐based NGBs, focusing on support for athletes ...
Mohammed Abdel‐Magid, Emma J. Cockcroft, Chris Bright, Robert H. Mann, Richard Pulsford, Robert C. Andrews   +5 more
wiley   +1 more source

Low Carb Low Down: Facts About the Fad [PDF]

, 2018
The low carb diet is one of the most popular diets in nutrition. However, different sources will provide varying strategies for achieving a carb diet. The parameters of a typical low carb diet, the positive and negative side effects of the diet, and its ...
Bollinger, Chris
core   +1 more source

Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed‐methods study

Diabetic Medicine, EarlyView.
Abstract Aims Research and policy initiatives for type 1 diabetes (T1D) across European countries demonstrate an emergent, critical shift towards universal paediatric screening. National adaptations of screening, however, remain under‐researched. The current study, as part of the EU‐funded EDENT1FI programme, aimed to examine the psychosocial impact ...
O. Boiko, K. Barnard‐Kelly, J. Vercauteren, S. M. Greenfield, R. P. Dias, L. M. Quinn, I. Litchfield, T. Papanikolaou, J. L. Dunne, G. Perego, F. Gatti, F. Milano, B. M. Milazzo, V. Di Mattei, K. Lange, C. Mathieu, L. Overbergh, A.‐G. Ziegler, C. Hurtado Del Pozo, M. G. Scarale, A. Mahieu, A. J. Omar Alsaleh, E. Bosi, P. Narendran, on behalf of the EDENT1FI Consortium, C. Mathieu, P. Gillard, K. Casteels, B. van der Schueren, L. Overbergh, J. Vercauteren, A. G. Ziegler, P. Achenbach, F. Haupt, C. Winkler, S. Hummel, F. Reschke, O. Kordonouri, T. von dem Berge, K. Lange, T. Pieber, J. Mader, S. Moitzi, S. Del Prato, B. Torbeyns, Z. Sumnik, O. Cinek, V. Neuman, B. Berka, F. Pociot, B. Petersen, J. Antvorskov, J. H. Klaebel, R. Lahesmaa, H. Hyöty, J. E. Laiho, F. Reschke, O. Kordonouri, T. von dem Berge, E. Bonifacio, R. Berner, A. Hommel, A. Loff, G. Gemulla, N. Zubizarreta, E. Bosi, L. Piemonti, V. Lampasona, F. Dotta, G. Sebastiani, A. Szypowska, K. Karczewski, P. Jarosz‐Chobot, J. F. Raposo, R. Ribeiro, R. Coelho, M. Peakman, E. Niemoeller, M. Baccara‐Dinet, J. Van Rampelbergh, R. Bergholdt, K. Fogh, O. Cohen, M. I. Buompensiere, C. Hurtado del Pozo, E. Latres, G. Agiostratidou, A. Koralova, J. Jackson, D. Darrock, H. Tewson, S. Nagallas, J. Hedrick, K. Collins, T. Tree, C. Dayan, K. Hood, J. Townson, R. Playle, R. Besser, P. Narendran, I. Litchfield, S. Greenfield, R. Dias   +103 more
wiley   +1 more source

Evaluation of a novel eating disorder prevention programme (Australian diabetes body project) for young women with type 1 diabetes in a clinic setting: A randomized controlled trial protocol

Diabetic Medicine, EarlyView.
Abstract Background Co‐occurrence of eating disorders (ED) and type 1 diabetes (T1D) can lead to deterioration in glycaemic control with reduced quality of life, microvascular complications, diabetic ketoacidosis and premature death. The current trial aims to test the effectiveness of an Australian Diabetes Body Project (ADBP) programme, a cognitive ...
Neisha D'Silva, Kerri M. Gillespie, Christel Hendrieckx, Line Wisting, Tatjana Ewais, Liza Phillips, Simon Denny, Selena Bartlett, Melanie White, Hannah Mackay, Margaret Vitanza, Isabella Magee, Alison Griffin, Lee Jones, Eric Stice   +14 more
wiley   +1 more source

Immune checkpoint inhibitor-associated diabetic ketoacidosis and insulin-dependent diabetes: a case report

Journal of Medical Case Reports
Background Immunotherapy, including the use of immune checkpoint inhibitors such as nivolumab, is increasingly common in cancer treatment and can lead to various immune-related adverse effects, including rare cases of diabetic ketoacidosis.
Yungee Jung, Anthony Lau, Joseph Bednarczyk   +2 more
doaj   +1 more source

Pediatric non-diabetic ketoacidosis: a case-series report

BMC Pediatrics, 2017
Background This study is to explore the clinical characteristics, laboratory diagnosis, and treatment outcomes in pediatric patients with non-diabetic ketoacidosis. Methods Retrospective patient chart review was performed between March 2009 to March 2015.
Ke Bai, Yueqiang Fu, Chengjun Liu, Feng Xu, Min Zhu   +4 more
doaj   +1 more source

‘Darkness as we face the unknown’: Biopsychosocial‐spiritual experiences of parents of children and young people with type 1 diabetes from the Middle East and North Africa (MENA) region

Diabetic Medicine, EarlyView.
Abstract Aim Qualitative interviews were conducted as part of the development of a person‐reported outcome measure (PROM) to assess biopsychosocial‐spiritual outcomes of parents of children with type 1 diabetes (T1D) in the Middle East and North Africa (MENA) region.
Mariam Asaad, Haya Abu Ghazaleh, Vasiliki Tzouvara, Nada Aljohani, Shatha Alsayed, Jackie Sturt   +5 more
wiley   +1 more source

Exploring inequities in access to diabetes technologies among children and young people with type 1 diabetes: Perspectives of parents and young people from ethnic minority groups and low socio‐economic areas

Diabetic Medicine, EarlyView.
Abstract Aims Access to diabetes technology in the UK is significantly influenced by socio‐economic status, ethnicity, and systemic healthcare inequities. This study investigates barriers faced by children and young people (CYP) from ethnic minority backgrounds and/or low socio‐economic areas in accessing diabetes technologies, alongside strategies for
Eda Tonga, Mark Evans, Nick Oliver, Sze May Ng, Natalie Darko   +4 more
wiley   +1 more source

Psychosocial aspects of early detection in type 1 diabetes: Language matters, decision making and support needs

Diabetic Medicine, EarlyView.
Abstract Aim The potential implementation of early type 1 diabetes (T1D) detection pathways, encompassing autoantibody screening and longitudinal monitoring, raises important psychosocial considerations for ethical, person‐centred care. This review summarises evidence on the psychosocial impact of early T1D detection, identifying key evidence gaps and ...
Maartje de Wit, Laura Yvonne Klinker, Belinda Moore, Anna Boggiss, Lucía Feito Allonca, Mariam Asaad, Keely Bebbington, Bryan Cleal, Sasja Huisman, Per Winterdijk, Henk Jan Aanstoot, Christine Fransman, Elizabeth Holmes‐Truscott, Norbert Hermanns, Giesje Nefs   +14 more
wiley   +1 more source

Safety and efficacy of intermittent fasting with or without exercise in people living with overweight or obesity and type 2 diabetes—The INTERFAST‐3 study design

Diabetic Medicine, EarlyView.
Abstract Aims Lifestyle modification, including caloric restriction and exercise, is fundamental in the treatment of people living with overweight and type 2 diabetes mellitus (T2D). The overall aim of lifestyle intervention schemes is to reduce body weight and improve glycaemic control to reduce the future risk of diabetes‐associated complications ...
Caren Sourij, Alexander Müller, Abdullah Al‐Baghdadi, Faisal Aziz, Norbert J. Tripolt, Peter N. Pferschy, Eva Andritz, Harald Kojzar, Vanessa Stadlbauer, Sabrina Leal Garcia, Harald Sourij   +10 more
wiley   +1 more source